The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...

Forty boxes recently arrived at a mostly empty lab space in University City where the Wistar Institute opened this month a research center that seeks to cure HIV. Soon, the boxes will be unpacked by a ...

Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...

Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...

The first HIV cure case in which the stem cell donor had a single — rather than double — gene mutation is opening the donor pool in renewed cure efforts to make stem cell transplants more widely ...

A Mississippi child who had undetectable HIV for more than two years off antiretroviral treatment has been found to still be infected, tempering optimism about a functional cure, researchers recently ...

The human immunodeficiency virus (HIV), the virus that causes healthy adults to become immunosuppressed, integrates its viral genetic code into the genome of the immune CD4+ T cells. While ...

MINNEAPOLIS — A newly approved prevention treatment for HIV will soon hit the market for Minnesotans, despite recent cuts to public health agencies spearheaded by the U.S. Health and Human Services ...

The claim: New $40,000 twice yearly shot is 'AIDS cure' A Dec. 2 Instagram post (direct link, archive link) shows a syringe extracting fluid from a vial and claims a cure has been developed for a ...

Gilead Sciences (GILD) is drawing attention this week as it presents new clinical results at both the European AIDS ...

The UK has approved a long-acting HIV jab that requires just one injection every two months. Doctors call it a breakthrough ...